Transcatheter arterial chemoembolization (TACE) has now been widely used in unresectable liver cancer, and also used in liver cancer complicated with portal vein tumor thrombus (PVTT). Here, the authors address the issues of application of TACE in liver cancer with PVTT, and the complications as well as the aspects that need to be improved.